Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Bone Biologics Corp (NASDAQ: BBLG) closed at $4.58 up 10.10% from its previous closing price of $4.16. In other words, the price has increased by $10.10 from its previous closing price. On the day, 26.57 million shares were traded. BBLG stock price reached its highest trading level at $6.19 during the session, while it also had its lowest trading level at $4.51.
Ratios:
For a deeper understanding of Bone Biologics Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.59 and its Current Ratio is at 12.59. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBLG now has a Market Capitalization of 2496892 and an Enterprise Value of -249658.
Stock Price History:
Over the past 52 weeks, BBLG has reached a high of $25.50, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -1.87%, while the 200-Day Moving Average is calculated to be -30.66%.
Shares Statistics:
For the past three months, BBLG has traded an average of 39.35K shares per day and 2735690 over the past ten days. A total of 0.55M shares are outstanding, with a floating share count of 0.54M. Insiders hold about 0.12% of the company’s shares, while institutions hold 0.80% stake in the company. Shares short for BBLG as of 1749772800 were 29866 with a Short Ratio of 0.76, compared to 1747267200 on 14316. Therefore, it implies a Short% of Shares Outstanding of 29866 and a Short% of Float of 5.48.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
